NARF anticorps (Middle Region)
Aperçu rapide pour NARF anticorps (Middle Region) (ABIN928727)
Antigène
Voir toutes NARF AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- Middle Region
-
Purification
- Purified
-
Immunogène
- NARF antibody was raised in rabbit using the middle region of NARF as the immunogen
-
-
-
-
Indications d'application
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
NARF Blocking Peptide, (ABIN5614915), is also available for use as a blocking control in assays to test for specificity of this NARF antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- NARF (Nuclear Prelamin A Recognition Factor (NARF))
-
Autre désignation
- NARF
-
Sujet
- Several proteins have been found to be prenylated and methylated at their carboxyl-terminal ends. Prenylation was initially believed to be important only for membrane attachment. However, another role for prenylation appears to be its importance in protein-protein interactions. The only nuclear proteins known to be prenylated in mammalian cells are prelamin A- and B-type lamins. Prelamin A is farnesylated and carboxymethylated on the cysteine residue of a carboxyl-terminal CaaX motif. This post-translationally modified cysteine residue is removed from prelamin A when it is endoproteolytically processed into mature lamin A. NARF binds to the prenylated prelamin A carboxyl-terminal tail domain. Synonyms: Polyclonal NARF antibody, Anti-NARF antibody, nuclear prelamin A recognition factor antibody, DKFZp434G0420 antibody, FLJ10067 antibody, IOP2 antibody.
Antigène
-